Platinum Industr Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 24 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.2K Cr
Platinum Industries targets over 40% revenue growth in FY27. Platinum Industries targets a **40% revenue growth in FY27**, driven mainly by the Indian facility (90%) and 10% from the Egypt facility starting Q3 FY27.
From Platinum Industr's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹215
Market Cap
₹1.2K Cr
P/E Ratio
23.3
How does Platinum Industr rank in Chemicals & Petrochemicals?
Compare Platinum Industr against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Platinum Industr — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹132 Cr, net profit ₹15 Cr.
Full financials →📊 Revenue & Sales Performance
- →Platinum Industries targets over 40% revenue growth in FY27.
- →They expect about 10% of FY27 revenue from the Egypt facility; the rest from India.
- →Aiming for a 35% CAGR from FY26 to FY29 driven by facility ramp-ups, product innovation, and geographic diversification.
- →Growth to be led by increased contributions from CPVC and lead-free products.
- →CPVC sales accounted for ~30% of revenue in FY26 and expected to grow significantly.
- →Egypt plant expected to start commercial operations in Q3 FY27 with a potential peak revenue of over INR 600 crore.
- →Oleo chemicals segment has started sales in FY26 and expected to contribute meaningfully with a target of INR 55-60 crore revenue in FY27.
- →Capacity expansions in India (Palghar facility) planned with optimized utilization to support growth.
- →Focus on new product introductions across polymer families to support future growth.
📈 Profitability & Margins
- →Platinum Industries targets a **40% revenue growth in FY27**, driven mainly by the Indian facility (90%) and 10% from the Egypt facility starting Q3 FY27.
- →They aim for a **35% CAGR in revenue from FY26 to FY29**, supported by scaling up the Egypt plant and expanded Indian operations.
- →EBITDA margins are expected to stabilize between **13%-15% in FY27**.
- →Growth drivers include increasing sales of **CPVC and lead-free products**, which contributed 30% of FY26 revenue, and further expansion in **oleo chemicals**.
- →Egypt plant’s peak revenue potential is projected to exceed **INR 600 crore**, with breakeven at around 30-35% utilization.
- →Operating efficiencies, new product introductions, and innovation in sustainability are expected to enhance profitability.
- →Strong financial discipline and cost optimization efforts are anticipated to sustain **PAT growth in line with revenue expansion**.
🏗️ Capital Expenditure Plans
- →Platinum Industries is investing in expanding production capabilities at the Indian facility, including the Palghar plant, and setting up the new manufacturing facility in Egypt, expected to start commercial operations in Q3 FY27.
- →They are building capacities for oleo-based derivatives with design and setup already started; the oleo chemicals plant readiness is expected within the next 1.5 years.
- →No immediate CapEx plans for manufacturing footprint expansion in Europe or the US, but the company is studying these markets and remains open to opportunities when viable.
- →CapEx during FY26 focused on capacity expansion at Indian and Egypt plants, aligning with long-term growth and diversification strategies.
- →Emphasis on capacity augmentation, technology upgrades, and R&D investments to support sustainable growth and product innovation.
💰 Fundraising & Capital Structure
- →No explicit mention of any current or planned fundraising through debt or equity was made during the call.
- →The company emphasized a strong liquidity position to fund ongoing operations and future investments.
- →Net debt remained minimal, reflecting prudent financial management.
- →The management highlighted plans to invest in capacity expansion and new facilities, including the Egypt plant and oleo chemical plant, supported by internal accruals.
- →They reiterated maintaining financial discipline while investing in capacity, technology, and R&D.
- →No concrete CapEx plans were shared for new plants in Europe or the US.
- →Overall, the focus is on organic growth funded through internal resources without mentioning fresh equity or debt raises.
📋 Order Book & Pipeline
Key Metrics
Continue your research
What Platinum Industr's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- NOCIL (Q4 FY26)
The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…
- Rossari Biotech (Q4 FY26)
50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…
- Pidilite Inds. (Q4 FY26)
Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…
- PCBL Chemical Ltd (Q4 FY26)
The company has reduced overall borrowings by approximately INR 450 crores in the current year. Key concall takeaways from PCBL Chemical's Q4 FY26 earnings…
Frequently Asked Questions
What were Platinum Industr Q4 FY26 results?
Platinum Industries targets over 40% revenue growth in FY27. Platinum Industries targets a **40% revenue growth in FY27**, driven mainly by the Indian facility (90%) and 10% from the Egypt facility starting Q3 FY27.
What is Platinum Industr share price analysis?
Platinum Industr currently shows a neutral. The stock trades at a P/E of 23.3 with a market cap of ₹1,183 Cr. Investors should review the full earnings analysis for detailed insights.
Is Platinum Industr planning capital expenditure?
Platinum Industries is investing in expanding production capabilities at the Indian facility, including the Palghar plant, and setting up the new manufacturing facility in Egypt, expected to start commercial operations in Q3 FY27.
Keep Platinum Industr on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.